ImmunoPrecise Antibodies Retained Earnings (Accumulated Deficit) 2022-2024 | IPA

ImmunoPrecise Antibodies retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

ImmunoPrecise Antibodies Retained Earnings (Accumulated Deficit) 2022-2024 | IPA

ImmunoPrecise Antibodies retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$9.2B
Inspire Medical Systems (INSP)$5.7B
Hims & Hers Health (HIMS)$5.5B
Enovis (ENOV)$2.6B
Privia Health (PRVA)$2.6B
IRhythm Technologies (IRTC)$2.3B
Azenta (AZTA)$2.2B
Omnicell (OMCL)$2.1B
10x Genomics (TXG)$1.7B
Clover Health Investments (CLOV)$1.7B
Schrodinger (SDGR)$1.5B
Phreesia (PHR)$1.1B
Butterfly Network (BFLY)$690M
Standard BioTools (LAB)$596M
Talkspace (TALK)$583M
Fulgent Genetics (FLGT)$547M
Definitive Healthcare (DH)$505M
Health Catalyst (HCAT)$495M
Pulmonx (LUNG)$268M
TruBridge (TBRG)$247M
SOPHiA GENETICS SA (SOPH)$209M
American Well (AMWL)$124M
EUDA Health Holdings (EUDA)$112M
P3 Health Partners (PIII)$76M
HeartBeam (BEAT)$74M
111 (YI)$52M
CareCloud (CCLD)$46M
Outset Medical (OM)$44M
SHL Telemedicine (SHLT)$42M
Zepp Health (ZEPP)$37M